This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEA601E0_M.jpg
The company is offering its equity shares in the price range of ₹92 to ₹97 per share, aiming to raise ₹45.16 crore (INR100 crore = approx. $12 million) at the upper price band. The offering comprises a total of 4,656,000 equity shares, with specific allocations for different investor categories including Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and market makers.
The company’s financial performance has been strong with a Compound Annual Growth Rate (CAGR) of 42.89% in revenue from FY2021 to FY2023. In FY2023, Saakshi Medtech & Panels Limited achieved a Revenue from Operations of ₹122.05 crore, with an Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of ₹20.34 crore and a Profit After Tax (PAT) of ₹12.38 crore.
Hem Securities Limited is the appointed book running lead manager for the issue, while Bigshare Services Pvt Ltd has been selected as the registrar. Investors and stakeholders are encouraged to review the company’s prospectus and consider participating in this opportunity.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
